|
Volumn 46, Issue 12, 2005, Pages 1138-1142
|
Case study in canine intestinal lymphangiectasia
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA 1 ANTITRYPSIN;
AMINOPENTAMIDE HYDROGEN SULFATE;
ANTIEMETIC AGENT;
ASPARTATE AMINOTRANSFERASE;
ATROPINE;
BUTORPHANOL TARTRATE;
CENTRINE;
CREATINE KINASE;
MEDETOMIDINE;
METOCLOPRAMIDE;
PREDNISOLONE;
SUCRALFATE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ARTICLE;
BLOOD CLOTTING TIME;
BODY CONSTITUTION;
CONSERVATIVE TREATMENT;
COUGHING;
DIET THERAPY;
DIFFERENTIAL DIAGNOSIS;
DOG DISEASE;
DOSE RESPONSE;
ECHOGRAPHY;
ENDOSCOPY;
FECES ANALYSIS;
FEMALE;
FOLLOW UP;
HEART FAILURE;
HYPOALBUMINEMIA;
INTESTINE LYMPHANGIECTASIA;
LAPAROTOMY;
LIVER FAILURE;
LIVER FIBROSIS;
NONHUMAN;
PAIN;
PARACENTESIS;
PREMEDICATION;
PROGNOSIS;
PROTEIN LOSING GASTROENTEROPATHY;
RISK ASSESSMENT;
SCORING SYSTEM;
SURVIVAL TIME;
TREATMENT OUTCOME;
TRICUSPID VALVE REGURGITATION;
URINALYSIS;
VOMITING;
ANIMALS;
DIAGNOSIS, DIFFERENTIAL;
DOG DISEASES;
DOGS;
FEMALE;
IMMUNOSUPPRESSIVE AGENTS;
LYMPHANGIECTASIS, INTESTINAL;
TREATMENT OUTCOME;
ANIMALIA;
CANIS FAMILIARIS;
|
EID: 30644462964
PISSN: 00085286
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (9)
|